EVT.DE Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (23 Apr 2024 @ 11:35):

Stats
Today's Volume	654 746
Average Volume	706 125
Market Cap	2.51B
EPS	€-0.220 ( 2023-11-08 )
Last Dividend	€0 ( N/A )
Next Dividend	€0 ( N/A )
P/E	-13.77
ATR14	€0.0140 (0.10%)

Volume Correlation

Long: 0.15 (neutral)

Short: -0.69 (moderate negative)

Signal:(56.66) Neutral

Evotec SE Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Evotec SE Correlation - Currency/Commodity

0.28
( neutral )

0.06
( neutral )

0.00
( neutral )

-0.10
( neutral )

0.29
( neutral )

Evotec SE Financials

Annual	2022
Revenue:	€751.45M
Gross Profit:	€174.07M (23.16 %)
EPS:	€-0.990

Q3	2023
Revenue:	€196.28M
Gross Profit:	€37.82M (19.27 %)
EPS:	€-0.220

Q2	2023
Revenue:	€170.28M
Gross Profit:	€46.32M (27.20 %)
EPS:	€-0.0844

Q1	2023
Revenue:	€191.92M
Gross Profit:	€49.78M (25.94 %)
EPS:	€-0.0815

Financial Reports:

No articles found.

Evotec SE

Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as diabetes and complications of diabetes, fibrosis, infectious diseases, CNS diseases, oncology, pain and inflammation, immunology, rare diseases, respiratory diseases, and women's health. It has collaboration agreements with Bayer AG; Lilly; Chinook Therapeutics; Novo Nordisk A/S; Galapagos; Pfizer Inc.; CONBA Pharmaceutical Co., Ltd.; Bristol Myers Squibb Company; Zhejiang JingXin Pharmaceutical Co., Ltd; Kazia Therapeutics; Apeiron Biologics; and Takeda Pharmaceuticals. The company was formerly known as Evotec AG and changed its name to Evotec SE in April 2019. Evotec SE was incorporated in 1993 and is headquartered in Hamburg, Germany.